ZimVie Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
February 28, 2024 at 09:11 pm
Share
ZimVie Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 113.07 million compared to USD 116.55 million a year ago. Revenue was USD 113.07 million compared to USD 116.55 million a year ago. Net loss was USD 334.85 million compared to USD 30.34 million a year ago. Basic loss per share from continuing operations was USD 0.83 compared to USD 0.59 a year ago. Diluted loss per share from continuing operations was USD 0.83 compared to USD 0.59 a year ago. Basic loss per share was USD 12.59 compared to USD 1.16 a year ago. Diluted loss per share was USD 12.59 compared to USD 1.16 a year ago.
For the full year, sales was USD 457.43 million compared to USD 463.29 million a year ago. Revenue was USD 457.43 million compared to USD 463.29 million a year ago. Net loss was USD 393.28 million compared to USD 63.88 million a year ago. Basic loss per share from continuing operations was USD 2.12 compared to USD 1.8 a year ago. Diluted loss per share from continuing operations was USD 2.12 compared to USD 1.8 a year ago. Basic loss per share was USD 14.87 compared to USD 2.45 a year ago. Diluted loss per share was USD 14.87 compared to USD 2.45 a year ago.
ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.